Blood and CSF tests for autoimmune diseases
| Requested analysis | Results |
| Anti-transglutaminase (blood) | Negative |
| Ant-IgA (blood) | Negative |
| ACE (blood) | Below determination threshold |
| Anti-Hu (blood) | Negative |
| Anti-Yo (blood) | Negative |
| Anti-Ri (blood) | Negative |
| Anti-CV2 (blood) | Negative |
| Anti.amphiphysin (blood) | Negative |
| Anti-Ma2/Ta (blood) | Negative |
| Anti-Tr (blood) | Negative |
| Anti-SOX1 (blood) | Negative |
| Anti-Zic4 (blood) | Negative |
| Anti-GAD65 (blood) | Negative |
| Anti-recoverin (blood) | Negative |
| Anti-titin (blood) | Negative |
| Anti-NMDAR (CSF) | Negative |
| Anti-AMPAR (CSF) | Negative |
| Anti-GABABR (CSF) | Negative |
| Anti-LGI1 (CSF) | Negative |
| Anti-CASPR2 (CSF) | Negative |
| Anti-DPPX (CSF) | Negative |
| Anti-MGLUR-1 (CSF) | Negative |
| Anti-MGLUR-5 (CSF) | Negative |
| Anti-GFAP (CSF) | Positive (by immunoreactivity tests, confirmed with cell-based assay (CBA)) |
ADA, adenosine deaminase; AMPAR, anti-alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor; CASPR2, conectin-associated protein 2; CSF, cerebrospinal fluid; DPPX, dipeptidyl-peptidase-like protein 6; GABABR, gamma-aminobutyric acid type B receptor; GFAP, glial fibrillary acidic protein; LGI1, leucine-rich glioma-inactivated 1; MGLUR-1, metabotropic glutamate receptor 1; MGLUR-5, metabotropic glutamate receptor 5; NMDAR, N-methyl-D-aspartic receptor.